Propranolol Hydrochloride

Propranolol Hydrochloride, a beta-blocker medication, is being studied in various clinical trials to explore its potential benefits beyond its traditional uses. These trials are investigating the drug’s effectiveness in treating conditions such as soft tissue sarcoma, hepatic hemangioma, anxiety during dental procedures, and even as a potential aid in labor and delivery. The research aims to provide new insights into the drug’s capabilities and expand its therapeutic applications.

Table of Contents

What is Propranolol Hydrochloride?

Propranolol hydrochloride is a medication that belongs to a class of drugs called beta-blockers. It is also known by other names such as Inderal, Avlocardyl, and APO-PROPRANOLOL[2]. Propranolol works by blocking the effects of certain stress hormones like epinephrine (also called adrenaline) on the heart and blood vessels[3].

Uses of Propranolol

Propranolol is used to treat various conditions, including:

  • High blood pressure: It helps lower blood pressure by reducing the workload on the heart[1].
  • Anxiety: It can help reduce physical symptoms of anxiety like rapid heartbeat and trembling[1].
  • Migraine prevention: Regular use may help prevent migraine headaches[1].
  • Tremors: It can help reduce shaking in conditions like essential tremor[1].
  • Infantile hemangiomas: These are benign (non-cancerous) growths of blood vessels in infants. Propranolol has become a standard treatment for this condition[3].

How Propranolol Works

Propranolol works by blocking beta-adrenergic receptors in the body. These receptors normally respond to stress hormones like adrenaline. By blocking these receptors, propranolol can:

  • Slow down heart rate
  • Reduce blood pressure
  • Decrease anxiety symptoms
  • Potentially affect the growth of certain types of tumors

Recent research suggests that propranolol might also have effects on blood vessel growth and tumor development, which is why it’s being studied for conditions like hemangiomas and certain cancers[3][4].

Dosage and Administration

The dosage of propranolol can vary widely depending on the condition being treated and the individual patient. Some examples from the clinical trials include:

  • For dental anxiety: 40 mg to 320 mg per day[1]
  • For traumatic memories: 40 mg of regular propranolol followed by 60 mg of long-acting propranolol[2]
  • For liver hemangiomas in adults: Starting at 30 mg per day, increasing to 1.5 mg per kilogram of body weight per day[5]

It’s crucial to take propranolol exactly as prescribed by your doctor. Never adjust your dose without medical supervision.

Potential Side Effects

While propranolol is generally considered safe, it can cause side effects. Most side effects are mild and self-limiting[1]. Common side effects may include:

  • Fatigue
  • Dizziness
  • Cold hands and feet
  • Slow heart rate
  • Sleep disturbances

More serious side effects are rare but can occur. Always inform your doctor of any side effects you experience.

Ongoing Research and Potential New Uses

Several clinical trials are exploring new potential uses for propranolol:

  • Cancer treatment: Studies are investigating whether propranolol might help in treating certain types of cancer, including melanoma and soft tissue sarcomas[4][6]. The idea is that propranolol might help slow tumor growth by affecting blood vessel formation.
  • Post-traumatic stress disorder (PTSD): Researchers are studying whether propranolol can help reduce the emotional impact of traumatic memories in people with PTSD[2].
  • Labor induction: One study is looking at whether propranolol can help speed up labor induction when used alongside oxytocin (a hormone that stimulates contractions)[7].
  • Adult liver hemangiomas: While propranolol is already used for infantile hemangiomas, researchers are now studying its effectiveness in treating liver hemangiomas in adults[5].

It’s important to note that these are areas of ongoing research. Propranolol is not yet approved for these uses, and patients should not use propranolol for these conditions unless under the direct supervision of a doctor in a clinical trial setting.

Condition Study Type Key Findings/Objectives
Metastatic Soft Tissue Sarcoma Randomized Controlled Trial Combining Propranolol with chemotherapy to assess Progression Free Survival and Overall Survival
Hepatic Hemangioma Phase II Study Evaluating Propranolol’s effectiveness in controlling tumor size and progression
Anxiety in Mechanical Ventilation Open-label Randomized Controlled Trial Assessing Propranolol’s potential to reduce sedative use in critically ill patients
Kaposi Sarcoma Phase II Study Investigating Propranolol’s efficacy in treating Kaposi sarcoma lesions
Post-traumatic Stress Disorder Double-blind Randomized Controlled Trial Examining Propranolol’s effects on perioperative complications in PTSD patients
Dental Anxiety Randomized Placebo-controlled Trial Evaluating Propranolol’s anxiolytic effects during dental extractions
Prolonged Labor Randomized Controlled Trial Assessing whether Propranolol can reduce time to delivery in cases of labor dystocia

Ongoing Clinical Trials on Propranolol Hydrochloride

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    1 1 1 1
    Spain
  • Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors

    Recruiting

    1 1 1
    France
  • Study Comparing Amitriptyline, Flunarizine, Topiramate, and Propranolol for Preventing Migraines in Primary Care Patients

    Recruiting

    1 1 1 1
    Spain
  • Study on Propranolol and Pembrolizumab for Patients with Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma

    Recruiting

    1 1 1
    Investigated diseases:
    Denmark Norway Sweden
  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    1 1 1
    Austria Germany
  • Study on the Effectiveness of Reconsolidation Therapy with Propranolol for Patients with Severe Post-Traumatic Stress Disorder

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on the Effects of Bisoprolol Fumarate, Hydrochlorothiazide, and Metoprolol in Patients with Idiopathic Ventricular Fibrillation After Cardiac Arrest

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark
  • Study on Oral Propranolol for Preventing Severe Retinopathy in Premature Infants

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • A Study Testing Propranolol for Patients with Traumatic Brain Injury Who Need Intensive Care Unit Treatment

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Spain

Glossary

  • Beta-adrenergic receptor blocker: A type of medication that blocks the effects of adrenaline and noradrenaline on beta receptors in the body, often used to treat high blood pressure and certain heart conditions.
  • Metastatic soft tissue sarcoma: A type of cancer that begins in the soft tissues of the body (such as muscle, fat, or blood vessels) and has spread to other parts of the body.
  • Hepatic hemangioma: A noncancerous tumor in the liver made up of blood vessels.
  • Progression Free Survival (PFS): The length of time during and after treatment that a patient lives with the disease but it does not get worse.
  • Overall Survival (OS): The length of time from the start of treatment for a disease that patients are still alive.
  • Chorioamnionitis: An inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection.
  • Hypoxic ischemic encephalopathy: A type of brain damage that occurs when an infant experiences a lack of oxygen and/or blood flow to the brain near the time of birth.
  • Kaposi sarcoma: A type of cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat, or in other organs.

References

  1. https://clinicaltrials.gov/study/NCT02268357
  2. https://clinicaltrials.gov/study/NCT01069159
  3. https://clinicaltrials.gov/study/NCT02732678
  4. https://clinicaltrials.gov/study/NCT01988831
  5. https://clinicaltrials.gov/study/NCT03633747
  6. https://clinicaltrials.gov/study/NCT03108300
  7. https://clinicaltrials.gov/study/NCT05251610